BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2023
Biohit Oyj Half Year Financial Report 9 August 2023 at 9:30 am local time (EET) SUMMARY January-June 2023 · Revenue EUR 6.5 million (EUR 6.1 million) · Revenue increased by 6.2% compared to H1/2022 · Operative EBITDA EUR 1.8 million (EUR 1.7 million) · EBIT EUR 1.5 million (EUR 1.3 million) · Cash at the end of the period EUR 1.7 million (EUR 2.1 million 31 December 2022) · Fair value of Genetic Analysis AS investment EUR 0.2 million (EUR 0.3 million 31 December 2022) · Revenue from international operations 98.4% (98.2%) of total revenue · Equity ratio 73.2% (